PHARMING GROUP NV's ticker is PHAR and the CUSIP is 71716E105. A total of 5 filers reported holding PHARMING GROUP NV in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $11,894 | -13.8% | 881 | -29.6% | 0.00% | – |
| Q4 2022 | $13,799 | -8.0% | 1,251 | -18.4% | 0.00% | – |
| Q3 2022 | $15,000 | +15.4% | 1,534 | +4.2% | 0.00% | – |
| Q2 2022 | $13,000 | +18.2% | 1,472 | +16.6% | 0.00% | – |
| Q1 2022 | $11,000 | -8.3% | 1,262 | -5.0% | 0.00% | – |
| Q4 2021 | $12,000 | +1100.0% | 1,328 | +1064.9% | 0.00% | – |
| Q3 2021 | $1,000 | -93.3% | 114 | -91.4% | 0.00% | – |
| Q2 2021 | $15,000 | -53.1% | 1,319 | -47.4% | 0.00% | – |
| Q1 2021 | $32,000 | +128.6% | 2,508 | +173.8% | 0.00% | – |
| Q4 2020 | $14,000 | – | 916 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cowen Prime Advisors LLC | 15,850 | $142,000 | 0.06% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 2,500 | $22,000 | 0.00% |
| UBS Group AG | 1,262 | $11,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 974 | $9,000 | 0.00% |